Related Experiment Videos
Chronic nicotine administration increases NGF-like immunoreactivity in frontoparietal cerebral cortex
R Martínez-Rodríguez1, A Toledano, M I Alvarez
1Experimental Research Centre, La Paz Hospital, Madrid, Spain.
Journal of Neuroscience Research
|August 21, 2003
Summary
Nicotine treatment increased nerve growth factor (NGF) in rat brain cortex neurons and glial cells. This suggests nicotine
Area of Science:
- Neuroscience
- Pharmacology
- Cell Biology
Background:
- Nicotine and its agonists are investigated for treating neurodegenerative diseases like Alzheimer's.
- The precise mechanisms underlying nicotine's effects on the nervous system are not fully understood.
- Nerve Growth Factor (NGF) plays a crucial role in neuronal survival and function.
Purpose of the Study:
- To investigate the impact of chronic nicotine administration on NGF expression in the rat frontoparietal cortex.
- To elucidate the cellular localization of nicotine-induced NGF changes in neurons and glial cells.
Main Methods:
- Chronic intraperitoneal administration of nicotine (0.35 mg/kg/day for 14 days) using osmotic pumps in albino rats.
- Immunohistochemical techniques to detect NGF-like positive cells and structures in the frontoparietal cortex.
- Electron microscopy to confirm the cellular identity of immunopositive prolongations.
Main Results:
- Increased number and immunoreaction intensity of NGF-positive pyramidal and nonpyramidal neurons in nicotine-treated rats.
- Presence of immunopositive astroglial cells exclusively in nicotine-treated animals.
- Identification of immunopositive neuronal (dendrites, axons) and astroglial prolongations in the neuropil of treated rats.
Conclusions:
- Chronic nicotine exposure stimulates NGF production in cortical neurons and glial cells.
- Nicotinic activation appears to engage NGF/neurotrophic mechanisms.
- Findings support the potential therapeutic benefit of nicotine or its agonists in neurodegenerative disease prevention and treatment.